SGLT2 and DPP4 Inhibition: An Ideal Combination
This article discusses the evidence for the combination use of SGLT2 inhibitors and DPP4 inhibitors, in addition to standard care, in the management of type 2 diabetes.
Written by Prof Merlin Thomas MBChB, PhD, FRACP
Prof Merlin Thomas is a Professor of Medicine at Monash University, Melbourne. Prof Thomas is both a physician and a research scientist. He has published over 300 articles in many of the world’s leading medical journals, as well as several books including The Longevity List and Fast Living, Slow Ageing. He is an internationally recognised speaker, opinion-leader, teacher and medical storyteller. His research focuses on discovering new ways to prevent and treat the complications of diabetes.